Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis
SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today that the findings of reduction in proteinuria and stabilization of eGFR in a Chinese subpopulation after 9 months of treatment...
Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business
NEW YORK, April 6, 2022 /PRNewswire/ -- Mindtree, a global technology services and digital transformation company, today announced that it has made a strategic investment in COPE Health Solutions, a leading U.S. healthcare consulting, implementation, and co-management leader in value-based care and payment, workforce development and data analytics, to expand its healthcare business....
Digital Engagement Continues to Soar Amongst Biopharmas in APAC
SYDNEY, April 6, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released 2021 industry-wide Veeva Pulse data that shows the continued growth of digital engagement across the Asia Pacific* life sciences industry. Since the start of the COVID-19 pandemic, digital communication between biopharmas and healthcare professionals (HCPs) has steadily increased in this region....
Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals
SAN DIEGO and TOKYO, April 5, 2022 /PRNewswire/ -- Singlera Genomics Inc. today announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to better understand biological reactions to pharmaceuticals using Singlera's mTitan platform. mTitan allows for the interrogation of rare circulating cell-free DNA methylation signals, and has previously been utilized to non-invasively detect cancer signals in...
Infobird Signs Contract with Taikang Healthcare Investment Holdings to Upgrade Contact Center and AI Chatbot Services for Elder Care
Digital contact center and chatbots provide efficient and intelligent customer services to enhance visibility across the organization, as well as higher customer satisfaction BEIJING, April 5, 2022 /PRNewswire/ – Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a leading provider of AI-powered customer engagement solutions in China, today announced that it signed a cooperation agreement with Taikang Healthcare Industry...
Nihon Medi-Physics Attains World’s First Manufacturing of Actinium-225 with Cyclotron on Production Scale for Investigational Drugs
- Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel Treatment for Cancer - TOKYO, April 5, 2022 /PRNewswire/ -- Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, announced on April 5, 2022, that the company has successfully manufactured actinium-225 (Ac-225), a core material used for Targeted Alpha (*1) Therapy (TAT), on a...
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK
LONDON, April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories...
Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions
SINGAPORE, April 5, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients requiring radiation therapy. As hospitals increasingly seek flexible and interoperable simulation and guidance technology, Elekta and...
TraceLink Launches its Opus Compliance Framework with the Release of the Brazil Compliance Solution on the Opus Platform
The Opus™ Compliance Framework Enables Rapid Development of Compliance Solutions To Keep Pace With Increasing Country Mandates BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company, announces the release of its Opus™ Compliance Framework with the release of the Brazil compliance solution on the Opus platform. The...
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company,...
